Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies
The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Abstract
Two distinct CD28-specific mAb were used in treatment of active or adoptive transfer (AT)-experimental autoimmune neuritis (EAN): "superagonistic" JJ316 activates T cells without T cell receptor (TCR) occupancy, and conventional JJ319 activates T cells only in the presence of TCR-stimulation. Treatment with JJ316 during induction phase of active and adoptive-transfer experimental autoimmune encephalomyelitis (AT-EAN) dramatically reduced disease severity and improved nerve function as revealed by electrophysiology. JJ316 given 1 week before immunization had a preventive effect. By immunohistology, JJ316 markedly reduced TC infiltration of the sciatic nerve in active and AT-EAN. JJ319 was less effective. Ex vivo, JJ316 therapy reduced P2-specific proliferation and interferon-gamma (IFN-gamma) production of lymph node cells. We demonstrate preventive and therapeutic effects of a "superagonistic" mAb-mediated, TCR-independent CD28 stimulation in EAN, possibly with implications for therapy of autoimmune-inflammatory disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“similar reagents had shown efficacy in rodent models for treating autoimmune disease (2-4).”
From The calm after the cytokine storm: lessons from the TGN1412 trial (2008) · cites this paper as [3]
In the citing paper
“leading, as of today, to 25 original publications describing efficacious therapy in a large number of rat and mouse disease models”
From The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account (2016) · cites this paper as [5]
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506 · cited 4×
“Activation of CD4+ T cells can lead to the differentiation of functionally distinct Th cell subsets: pro-inflammatory Th1 cells produce interferon (IFN)-g, lymphotoxin (LT) and mediate delayed type hypersensitivity, while Th2 cells favor humoral immune responses via the production of IL-4, IL-5 and IL-10 (Mosmann et a…”
BackgroundInfluentialGlucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,504 · cited 1×
“Apoptosis was assessed by morphological criteria (Wyllie, 1980) or labeling by TUNEL.”
MethodThe expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633 · cited 1×
“…functionally distinct Th cell subsets: pro-inflammatory Th1 cells produce interferon (IFN)-g, lymphotoxin (LT) and mediate delayed type hypersensitivity, while Th2 cells favor humoral immune responses via the production of IL-4, IL-5 and IL-10 (Mosmann et al., 1986; Mosmann and Sad, 1996).”
BackgroundKuchroo, V. K., Prabhu Das, M., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., & Glimcher, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90349-6 · Cited by 1,641 · cited 1×
“Thus, anti-B7-1 ameliorated, while anti-B7-2 exacerbated disease, and anti B7-1 in combination with antiB7-2 was found to act either way, depending on the induction mode of EAE (Kuchroo et al., 1995; Miller et al., 1995; Perrin et al., 1996b; Racke et al., 1995).”
BackgroundDifferential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257 · cited 3×
“However, as illustrated by the phenotype of CD28 deficient mice (Shahinian et al., 1993), interference with CD28-mediated costimulation may tip the Th1/Th2 balance towards the pro-inflammatory Th1 phenotype, thus entailing the danger of actually exacerbating autoimmuneinflammatory responses in some situations.”
BackgroundInfluentialRegulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236 · cited 2×
“…been described, among them a ‘‘regulatory’’ population phenotypically defined by CD25 expression that produces the anti-inflammatory cytokines IL-10 and transforming growth factor (TGF)-h and plays an important role in the suppression of autoimmunity and inflammation (reviewed in Shevach, 2000).”
BackgroundComplexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006 · cited 2×
“These results reflect the complexity and unpredictability of the system at several levels: the importance of, but not absolute requirement for, CD28mediated costimulation in initial T cell activation; the influence of CD28 signals on Th1/Th2 development; the distinct cellular expression patterns of B7-1 and B7-2; and…”
BackgroundResultKohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Gold, R., Schmied, M. C., Giegerich, G., Breitschopf, H., Hartung, H., Toyka, K. V., & Lassmann, H. (1994) · PubMed · Cited by 675
Self-citationNew perspectives of C1328-137-mediated T cell costimulation
Bluestone, J. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90000-4 · Cited by 513 · cited 1×
“The most potent costimulatory sig- nal known to date is mediated by the T cell surface receptor CD28 interacting with CD80 (B7-1) or CD86 (B7-2) on antigen presenting cells (APCs) (Hara et al., 1985; Blue- stone, 1995).”
Background
Cited by
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017
“In addition, preceding studies had revealed therapeutic activity also in experimental neuritis (Schmidt et al., 2003a).”
BackgroundSelf-citationThe CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Riley, J. L., & June, C. H. (2005) · Blood · doi:10.1182/blood-2004-04-1596 · Cited by 315
Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051060 · Cited by 203
“In a previous report, we showed that high-dose superagonistic CD28 treatment had a beneficial prophylactic and therapeutic effect on the peripheral nervous system autoimmune disease, experimental autoimmune neuritis, of the Lewis rat (38).”
BackgroundSelf-citationAustin, P. J., Kim, C. F., Perera, C. J., & Moalem-Taylor, G. (2012) · Pain · doi:10.1016/j.pain.2012.06.005 · Cited by 180
“The protective role of Tregs has been demonstrated in several animal models of nervous system diseases including experimental autoimmune neuritis (EAN) [58,72], experimental autoimmune encephalomyelitis [6,32,51], and acute experimental stroke [35].”
BackgroundREVIEW ARTICLE: Regulatory T Cells and Their Role in Pregnancy
Leber, A., Teles, A., & Zenclussen, A. C. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00821.x · Cited by 162
Metadata
- Authors
- Schmidt, J., Elflein, K., Stienekemeier, M., Rodriguez-Palmero, M., Schneider, C., Toyka, K. V., Gold, R., & Hünig, T.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Gold, Ralf
- Hünig, Thomas
- Venue
- Journal of Neuroimmunology
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 140
- Issue
- 1-2
- Pages
- 143-152
- ISSN
- 0165-5728 (ISSN-L)
- OpenAlex
- W2044179880
- Semantic Scholar
- 420adc2123aff77f4053ec1b64db04ad308ea701
- Cited by
- 59
- References
- 42
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 3
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Neuroimmunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- experimental autoimmune neuritis, CD28, adoptive transfer, experimental autoimmune encephalomyelitis, T cell activation, disease prevention, immunomodulation, interferon-gamma, T cell infiltration, sciatic nerve, autoimmune inflammatory disease
- MeSH terms
- Animals, Antibodies, Monoclonal, Cell Division, Cell Line, Cell Movement, Cells, Cultured, Female, Immunity, Active, Immunosuppressive Agents, Injections, Intraperitoneal, Interferon-gamma, Lymphocyte Activation, Neuritis, Autoimmune, Experimental, Peptide Fragments, Rats, Inbred Lew, Sciatic Nerve, Severity of Illness Index, T-Lymphocytes, CD28 Antigens, Epitopes, T-Lymphocyte, Myelin P2 Protein, Adoptive Transfer, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies. https://app.cochat.ai/papers/10.1016/s0165-5728(03)00182-6
- The paper
- Schmidt, J., Elflein, K., Stienekemeier, M., Rodriguez-Palmero, M., Schneider, C., Toyka, K. V., Gold, R., & Hünig, T. (2003). Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies. Journal of Neuroimmunology. https://doi.org/10.1016/s0165-5728(03)00182-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.